KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Equity Average (2016 - 2025)

Amgen has reported Equity Average over the past 17 years, most recently at $9.1 billion for Q4 2025.

  • Quarterly results put Equity Average at $9.1 billion for Q4 2025, up 36.35% from a year ago — trailing twelve months through Dec 2025 was $9.1 billion (up 36.35% YoY), and the annual figure for FY2025 was $7.3 billion, up 20.03%.
  • Equity Average for Q4 2025 was $9.1 billion at Amgen, up from $8.5 billion in the prior quarter.
  • Over the last five years, Equity Average for AMGN hit a ceiling of $9.4 billion in Q1 2021 and a floor of $1.7 billion in Q2 2022.
  • Median Equity Average over the past 5 years was $6.7 billion (2024), compared with a mean of $6.3 billion.
  • Biggest five-year swings in Equity Average: crashed 81.03% in 2022 and later soared 263.69% in 2023.
  • Amgen's Equity Average stood at $7.5 billion in 2021, then tumbled by 50.97% to $3.7 billion in 2022, then surged by 89.88% to $6.9 billion in 2023, then dropped by 3.49% to $6.7 billion in 2024, then surged by 36.35% to $9.1 billion in 2025.
  • The last three reported values for Equity Average were $9.1 billion (Q4 2025), $8.5 billion (Q3 2025), and $6.8 billion (Q2 2025) per Business Quant data.